武汉云克隆科技股份有限公司

血管内皮生长因子受体1(VEGFR1)多克隆抗体

Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)

Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT

  • 血管内皮生长因子受体1(VEGFR1)多克隆抗体产品包装(模拟)
  • 血管内皮生长因子受体1(VEGFR1)多克隆抗体产品包装(模拟)
  • 血管内皮生长因子受体1(VEGFR1)多克隆抗体IHC图
  • PAB818Ra01.jpgFigure. Western Blot; Sample: Recombinant VEGFR1, Rat.
  • 血管内皮生长因子受体1(VEGFR1)多克隆抗体Western Blot; Sample: Lane1: ECV304 cell lysate; Lane2: Human Placenta lysate
    Primary Ab: 0.6µg/ml Rabbit Anti-Rat VEGFR1 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 血管内皮生长因子受体1(VEGFR1)多克隆抗体Western Blot; Sample: Human 293T cell lysate;
    Primary Ab: 1.5µg/ml Rabbit Anti-Rat VEGFR1 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对VEGFR1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别VEGFR1。

用法

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

参考文献

杂志参考文献
Clinical cardiologyGrowth Differentiation Factor 15 and Coronary Collateral Formation[PubMed: 20014173]
Microvascular ResearchMutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289]
Science AlertAntiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats[Scialert: Source]
Acta BiomaterAntioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study[PubMed: 26689470]
Naunyn Schmiedebergs Arch PharmacolThe multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis[PubMed: 26269412]
Acta BiomaterialiaAntioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study[Pubmed:26689470]
Journal of Cellular PhysiologyA Human 3D In Vitro Model to Assess the Relationship Between Osteoporosis and Disseminationto Bone of Breast Cancer Tumor Cells.[pubmed:27925188]
OncotargetFasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway.[pubmed:29262624]
PlacentaModulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery.[pubmed:28962687]
Acta BiomaterialiaSynergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment[Pubmed: 30445158]
Scientific ReportsAssociation between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea[Pubmed: 31882827]
JOURNAL OF DERMATOLOGICAL TREATMENTEffect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris[Pubmed: 32043381]
FASEB JOURNALCyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible …[Pubmed: 33205477]
Children (Basel)sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates[34438609]
Oxid Med Cell LongevReactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation[Pubmed:35693704]